Manchanda Ashley S, Kwan Alan C, Ishimori Mariko, Thomson Louise E J, Li Debiao, Berman Daniel S, Bairey Merz C Noel, Jefferies Caroline, Wei Janet
Barbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Front Cardiovasc Med. 2022 Apr 15;9:867155. doi: 10.3389/fcvm.2022.867155. eCollection 2022.
Chest pain is a common symptom in patients with systemic lupus erythematosus, an autoimmune disease that is associated with increased cardiovascular morbidity and mortality. While chest pain mechanisms can be multifactorial and often attributed to non-coronary or non-cardiac cardiac etiologies, emerging evidence suggests that ischemia with no obstructive coronary arteries (INOCA) is a prevalent condition in patients with chest pain and no obstructive coronary artery disease. Coronary microvascular dysfunction is reported in approximately half of SLE patients with suspected INOCA. In this mini review, we highlight the cardiovascular risk assessment, mechanisms of INOCA, and diagnostic approach for patients with SLE and suspected CMD.
胸痛是系统性红斑狼疮患者的常见症状,系统性红斑狼疮是一种自身免疫性疾病,与心血管疾病发病率和死亡率增加有关。虽然胸痛机制可能是多因素的,且通常归因于非冠状动脉或非心脏性病因,但新出现的证据表明,无阻塞性冠状动脉的心肌缺血(INOCA)在胸痛且无阻塞性冠状动脉疾病的患者中是一种普遍存在的情况。在疑似INOCA的系统性红斑狼疮患者中,约有一半报告存在冠状动脉微血管功能障碍。在这篇小型综述中,我们重点介绍了系统性红斑狼疮和疑似冠状动脉微血管功能障碍患者的心血管风险评估、INOCA的机制以及诊断方法。